JP2006512364A5 - - Google Patents

Download PDF

Info

Publication number
JP2006512364A5
JP2006512364A5 JP2004562206A JP2004562206A JP2006512364A5 JP 2006512364 A5 JP2006512364 A5 JP 2006512364A5 JP 2004562206 A JP2004562206 A JP 2004562206A JP 2004562206 A JP2004562206 A JP 2004562206A JP 2006512364 A5 JP2006512364 A5 JP 2006512364A5
Authority
JP
Japan
Prior art keywords
solvate
pharmaceutically acceptable
acceptable salt
compound
warm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004562206A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006512364A (ja
Filing date
Publication date
Priority claimed from SE0203820A external-priority patent/SE0203820D0/xx
Application filed filed Critical
Publication of JP2006512364A publication Critical patent/JP2006512364A/ja
Publication of JP2006512364A5 publication Critical patent/JP2006512364A5/ja
Pending legal-status Critical Current

Links

JP2004562206A 2002-12-20 2003-12-18 ケモカイン受容体ｃｃｒ５のモジュレーターとしての新規ピペリジン誘導体 Pending JP2006512364A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0203820A SE0203820D0 (sv) 2002-12-20 2002-12-20 chemical compounds
PCT/SE2003/002005 WO2004056808A1 (en) 2002-12-20 2003-12-18 Novel piperidine derivatives as modulators of chemokine receptor ccr5

Publications (2)

Publication Number Publication Date
JP2006512364A JP2006512364A (ja) 2006-04-13
JP2006512364A5 true JP2006512364A5 (enExample) 2007-02-08

Family

ID=20289969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004562206A Pending JP2006512364A (ja) 2002-12-20 2003-12-18 ケモカイン受容体ｃｃｒ５のモジュレーターとしての新規ピペリジン誘導体

Country Status (9)

Country Link
US (1) US20060069120A1 (enExample)
EP (1) EP1572683B1 (enExample)
JP (1) JP2006512364A (enExample)
AT (1) ATE342898T1 (enExample)
AU (1) AU2003288853A1 (enExample)
DE (1) DE60309206T2 (enExample)
ES (1) ES2274295T3 (enExample)
SE (1) SE0203820D0 (enExample)
WO (1) WO2004056808A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
TW200610761A (en) * 2004-04-23 2006-04-01 Astrazeneca Ab Chemical compounds
SE0401656D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
DK2146779T3 (en) * 2007-04-18 2016-11-28 Pfizer Prod Inc Sulfonylamid derivatives to treat abnormal cell growth.
AU2009286749A1 (en) * 2008-09-01 2010-03-04 Neurosearch A/S Piperidylpropionamide derivatives useful for the treatment of CNS disorders including depression and panic disorder
MX2011001846A (es) * 2008-09-01 2011-04-04 Neurosearch As Nuevos derivados de piperidina-4-acetamida y su uso como inhibidores de la reabsorcion del neurotransmisor de monoamina.
CN102822163B (zh) 2009-12-23 2016-01-20 艾恩伍德医药品股份有限公司 Crth2调节剂
CN102241664B (zh) * 2010-05-13 2014-11-12 上海医药工业研究院 芳烷二胺类衍生物及其作为抗抑郁症药物的应用
WO2012009137A1 (en) 2010-07-12 2012-01-19 Ironwood Pharmaceuticals, Inc. Crth2 modulators
US20130259830A1 (en) 2010-07-12 2013-10-03 Ironwood Pharmaceuticals, Inc. Crth2 modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL125658A0 (en) * 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
EP1013276A1 (en) * 1998-12-23 2000-06-28 Pfizer Inc. Aminoazacycloalkanes as CCR5 modulators
GB0011838D0 (en) * 2000-05-17 2000-07-05 Astrazeneca Ab Chemical compounds
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0108046D0 (en) * 2001-03-30 2001-05-23 Astrazeneca Ab Chemical compounds

Similar Documents

Publication Publication Date Title
JP6907173B2 (ja) スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用
US10577337B2 (en) Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
TW202341983A (zh) 用於降解突變kras蛋白之化合物及其應用
JP5815746B2 (ja) Ｃ型肝炎ウイルス阻害剤
NO20064151L (no) Nye forbindelser
ES2728199T3 (es) Indazoles sustituidos con amida como inhibidores de poli (ADP-ribosa) polimerasa (PARP)
TW201245149A (en) Processes and intermediates
EA033626B1 (ru) АМИНОЗАМЕЩЕННЫЕ ИМИДАЗО[1,2-а]ПИРИДИНКАРБОКСАМИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ И ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ ИХ
JP2006524662A5 (enExample)
TW200840568A (en) Novel diamide derivative
CZ287610B6 (cs) Pentanamidové deriváty a farmaceutický prostředek s jejich obsahem
JP2018509441A (ja) 水溶性プロドラッグ
AU2023385361A1 (en) 2-amino-n-(4-amino-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butan-2-yl)benzamide derivatives as protease inhibitors for treating or preventing coronavirus infection
JP2004525183A5 (enExample)
WO2024151465A1 (en) Protease inhibitors for treating or preventing coronavirus infection
US11634428B2 (en) Deuterated angiotensin-converting enzyme-2 (ACE-2) inhibitors
RU2005131735A (ru) Химические соединения
CA2534003A1 (en) 3-quinuclidinyl-n-biarylamides as nicotinic acetylcholine receptor agonists
US6545008B1 (en) Pyrimidine derivatives and processes for the preparation thereof
WO2004014873A1 (ja) 4-置換キナゾリン-8-カルボン酸アミド誘導体とその薬理上許容される付加塩
FR3050732B1 (fr) Nouveaux derives de phosphinolactones et leurs utilisations pharmaceutiques
RU2007102272A (ru) Замещенные дикетопиперазины в качестве антагонистов
TWI570119B (zh) （２ｓ）－３－［（３ｓ，４ｓ）－３－［（１ｒ）－１－羥乙基］－４－（４－甲氧基－３－｛［１－（５－甲基吡啶－２－基）吖丁啶－３－基］氧基｝苯基）－３－甲基吡咯啶－１－基］－３－氧代丙烷－１，２－二醇結晶型及其用途
JP2022533943A (ja) Ａｂｈｄ１２阻害剤並びにその作製及び使用方法
KR20180020119A (ko) 새로운 5형포스포디에스테라아제 억제제 및 그 용도